SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $215,000 | -76.5% | 166,806 | -60.5% | 0.03% | -71.0% |
Q3 2021 | $916,000 | -7.8% | 422,148 | +16.0% | 0.09% | -17.0% |
Q2 2021 | $993,000 | +158.6% | 363,887 | +147.6% | 0.11% | +75.0% |
Q1 2021 | $384,000 | -61.0% | 146,968 | -58.5% | 0.06% | -60.2% |
Q4 2020 | $985,000 | – | 354,265 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
Prosight Management, LP | 256,115 | $699,000 | 0.44% |
ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |